|
West Coast Clinical Trials, LLC Expands Executive Team with New Hire Yves Grenon, Vice President of Business Development and Strategic Planning
Cypress,
CA / August 1, 2007 /
--
West Coast
Clinical Trials, LLC
(“WCCT”) adds a new
member to its executive
team – Yves Grenon, VP
of Business Development.
West Coast Clinical
Trials is a growing
Early Phase Clinical CRO
and is proud to welcome
him to their
organization. Yves
Grenon will lead the
Business Development
team and play a crucial
role in the development
of WCCT’s clinical
research activities.
“Yves is a
significant asset to
West Coast Clinical
Trials, LLC,” said Dr. Kenneth Kim, CEO and founder. “His 14 years of
experience in the CRO
industry will further
increase the
organization’s strength.
In addition, Yves’
extensive intellectual
knowledge will
additionally integrate
with the management
team’s vision.”
Mr. Grenon has
more than 14 years of
drug development
industry experience
including international
experience in Europe and Japan. Most recently, Mr.
Grenon was the Executive
Director of Business
Development (Clinical &
Bioanalytical Innovator
Market), at Pharmanet,
formerly SFBC
International, where he
developed key markets
across US, Europe and
Japan,
and led the integration
of 5 clinical and
bioanalytical sites.
Prior to Pharmanet, Mr.
Grenon was the Senior
Director of Business
Development at MDS
Pharma Services, a
full-spectrum CRO, where
he was responsible for
the for the European
market and later on the
Japanese market.
Over the years, Mr.
Grenon has been
successful in
implementing new
processes for the
management of innovator
drug markets.
Mr. Grenon
holds a degree in life
sciences and furthered
his education in
Management at
McGill University,
Montréal,
Canada.
About West
Coast Clinical Trials,
LLC.
WCCT is an Early Stage
Clinical CRO, with full
service capabilities.
The company not only
performs healthy
volunteer studies, but
has a unique
differentiating feature
of excelling in various
ethno-bridging trials
targeting specific
ethnic groups
---Japanese bridging,
Chinese bridging, Asian
ethnicity, Hispanic, and
African American focused
studies. In
addition, WCCT has
expertise in a number of
special population
trials: allergy,
asthma, renal impaired, platelet aggregometry, and pediatric
trials.
For almost 10
years, WCCT has
conducted hundreds of
clinical studies
involving thousands of
patients for nationally
and internationally
recognized
pharmaceutical
companies.
WCCT’s mission is
to deliver early phase
clinical solutions for
drug development with
flexibility and
responsiveness that
meets our sponsors'
unique needs. The
company’s focus is to be
the center of excellence
for bridging medical
research into new
therapies that benefit
lives. For more
information, please
visit
www.wcctrials.com.
_____________________
Contact:
Yves Grenon
Vice President, Business
Development
West Coast Clinical
Trials, LLC
5630 Cerritos Ave.
Cypress, CA 90630 USA
Phone:
(714) 252-0783
Fax: (714) 252-0799
E-mail:
yvesg@wcctrials.com
_____________________
Source: West Coast
Clinical Trials, LLC |
